All Articles in the Category ‘News’

Seattle Children’s Verified as Level I Children’s Surgery Center

Seattle Children’s has been newly verified as a Level I Children’s Surgery Center by the American College of Surgeons (ACS). Seattle Children’s is the only children’s hospital in Washington, and one of only 21 in the United States, to achieve this highest level of certification for pediatric hospital surgical programs.

The Level I designation recognizes all surgical, procedural and many support programs and services at Seattle Children’s — more than 40 departments and programs in total — and represents a major accomplishment for all programs and services that interact with surgical patients.

The verification process was rigorous. Surveyors from ACS visited in March to review our surgery program’s structure, processes and clinical outcomes data in detail. Surveyors were impressed with many aspects of Seattle Children’s surgical programs, particularly the quality improvement programs and collaborative, multidisciplinary care. Read full post »

Renovated Clinic Re-opens as “Sand Point Clinic”

Seattle Children’s newly renovated Sand Point Clinic (formerly the Hartmann building, located immediately across the street from the hospital building) re-opened Oct. 23. The exterior of the building looks much the same, but the interior has been completely reconstructed to modernize the mechanical systems, improve the building’s efficiency and accommodate new clinical and administrative space.

Orthotics and Prosthetics, which used the building prior to renovation, has already moved back in and resumed seeing patients. The Endocrinology and Diabetes program will move in the first week of January. The building is better configured for the program’s new focus on providing education to newly diagnosed diabetes patients whenever possible in an outpatient setting rather than inpatient setting. Seattle Children’s has also updated its referral instructions for referring providers for the Diabetes program to require additional lab/test results before referring a newly diagnosed diabetes patient. Read full post »

Seattle Children’s Opens Building Cure

Seattle Children’s almost doubled the size of its downtown Seattle pediatric research campus with the opening last month of a new 12-story, $300 million facility at Terry Avenue and Stewart Street in Seattle’s biotech corridor. Building Cure houses 10 floors of new biomedical laboratory space, including “the Cure Factory,” capable of manufacturing cell-based therapies to treat up to 1,000 children per year.  It includes a 255-seat amphitheater and Science Discovery Lab to support STEM education programs for children and teens.


Read Seattle Children’s press release.

Read more from GeekWire. Read full post »

Research News: Transforming Treatment for Childhood Leukemia

Headshot of Todd Cooper

Todd Cooper

Seattle Children’s is embarking on a groundbreaking clinical trial that will potentially transform treatment methods for children with relapsed acute pediatric leukemia. The trial will test multiple targeted therapies simultaneously at up to 200 clinical sites worldwide, including Seattle Children’s.

“Our goal is to get everyone to the table and work together. We’ve come to realize that’s the only way to make further progress,” says Dr. Todd Cooper of Seattle Children’s, who will head the new clinical trial. Dr. Cooper is an oncologist and director of the Seattle Children’s High-Risk Leukemia Program. He will oversee the master screening trial where children with newly diagnosed and relapsed acute leukemia can choose to have their clinical and biologic information included in an international database. The database will serve many purposes, including helping to determine an individual child’s eligibility for a number of targeted clinical trials. The data will also be used to uncover new targets for therapy and serve as a rich source for groundbreaking discoveries.


Read full post »

Seattle Children’s Patient Navigators Help Yakima Valley Families Access Cancer Care

Collaboration between Seattle Children’s and community partners led by a farmworkers clinic in the Yakima Valley is improving cancer outcomes for children in non–English-speaking families who are more likely to miss out on lifesaving care. Growing evidence points to a strong connection between socioeconomic status and cancer survival rates in the United States, according to a recent article in U.S. News & World Report. Read full post »

Helping Parents Build Resilience When Their Child Has Cancer

In a study published in JAMA Network Open, Seattle Children’s researchers found that one-on-one sessions teaching skills through a tool called Promoting Resilience in Stress Management for Parents (PRISM-P) improved resilience and benefit finding, or personal growth, among parents of children with cancer. “This tells me we are doing what is perhaps most important for parents: helping them to know they can come back again tomorrow and that they can find some good in the bad. These two things will help both them and their families,” said Dr. Abby Rosenberg, a researcher at Seattle Children’s Research Institute and lead author of the study.

Read full post »

Free Evidence-Based Mobile App for Youth With Chronic Pain

Tonya Palermo

Tonya Palermo

Tonya Palermo, director of the Pediatric Pain and Sleep Innovations Lab at Seattle Children’s Research Institute, has released a free mobile application (app) for Android and iPhone to help youth ages 10 to 18 who are experiencing chronic pain. The app is based on content from the Web-based Management of Adolescent Pain (WebMAP) Internet program that has been tested in multiple clinical trials. It helps teens learn about chronic pain, set goals for increasing their physical activities, learn relaxation and imagery strategies, and receive interventions for problems with sleep and low mood. Read full post »

Advancing Understanding of Birth Defects of the Brain

In the largest genetic study of the most common birth defects of the brain diagnosed during pregnancy, researchers from Seattle Children’s Research Institute say their findings evolve our understanding of brain development. The findings will also change the information given to expecting parents when cerebellar malformations are detected prenatally. “If you have a child at risk for developmental challenges, it helps to know the cause and what’s going to happen. This study significantly advances our ability to answer those questions,” said Dr. William Dobyns, the senior author on the paper published in the American Journal of Human Genetics and an investigator in the Center for Integrative Brain Research. Dobyns and lead author, Dr. Kimberly Aldinger, identified 27 different genes as key contributors. Read full post »

Update About Our Operating Rooms

Providing safe, quality care is our most important responsibility at Seattle Children’s, and we are all committed to doing what is right to keep our patients safe. Thanks to community partners like you, we continue to uphold our commitment and deliver care to patients across our region. We are very sorry for the impact this has had on our patients, families and community partners.

Ongoing Improvements

In the coming months, we will make additional improvements to our air filtration system and install a new air handler. We have learned a great deal throughout this experience and will share our learnings with other hospitals and regulatory organizations. Learn more about the improvements we have implemented.

As we continue to implement additional, long-term and enhanced maintenance to our air handling and purification system, we expect intermittent, planned closures of our operating rooms. We will take great care to support patients and families during these maintenance activities.

Read full post »

Seattle Children’s Scientists Advance B-Cell Research

Scientists at Seattle Children’s Research Institute are paving the way to use gene-edited B cells — a type of white blood cell in the immune system — to treat a wide range of potential diseases that affect children, including hemophilia and other protein deficiency disorders, autoimmune diseases, and infectious diseases. If successful, their research would open the door to offering this experimental cell therapy as the first of its kind in clinical trials at Seattle Children’s in as soon as five years.

B cells play a central role in the immune system. When the body is confronted with an infection, B cells turn into plasma cells that release protective antibodies that both fight ongoing infections and prevent future ones. Unlike other cells of the immune system that have relatively short lifespans, plasma B cells can survive and continuously produce antibodies for decades. Read full post »